Antibody Market Size, Share, Growth & Industry Trends [2031]
Global Antibody Market
Segments - by Types, (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, And Others) by Technology, (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, And Others), by Applications (Proteomics, Drug Development, and Genomics), By End-users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and CROs), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
The global antibody market was valued at USD 147,431.4 Million in 2019 and is projected to reach USD 318,482.1 Million by 2027, expanding at a CAGR of 10.1% during the forecast period. An antibody is a protein component of the body's immune system that recognizes and neutralizes foreign organisms such as bacteria and viruses. After being exposed to a foreign substance known as an antigen, antibodies stay in the blood and protect against further exposure to the antigen. The demand for antibodies is growing owing to the increasing demand of fast recovery, growing number of patients with diabetic and cardiovascular disorders, rising number of research and development activities, and quick diagnosis techniques for dreadful diseases. Research and development activities in monoclonal antibodies are expected to create lucrative opportunities for the global antibody market in the future.
Market Dynamics
Testing kits are now available, allowing medical personnel and clinicians to acquire lab-quality, real-time diagnostic findings in minutes. Technological breakthroughs have improved the capabilities of testing systems. For example, the rapid antigen test for coronavirus is presented in minutes, allowing for quick and accurate sickness diagnosis. Diseases are healed by administering the necessary antibodies in the form of a vaccination or drug. Researchers are concentrating on antigen detection technologies and developments.
The number of people living with diabetes is rapidly increasing. Screening and early detection have the potential to save lives and avoid serious problems. Self-monitoring of blood glucose (SMBG) allows people with diabetes to assess their own blood sugar levels using a glycemic reader and finger-prick technology. To achieve long-term glycemic management, SMBG technology employs lancets, test strips, and blood glucose metres. Diabetes causes nerves and blood arteries that control the heart and blood flow in the body to deteriorate over time. As a result, an exogenous protein, such as insulin, is injected into the body to regulate blood sugar levels which is anticipated to fuel the growth of the market during the forecast period.
The research and development sector is concerned with new efforts initiated by firms or governments in the development of new goods or services or the improvement of current ones. The primary focus is on biosimilar antibodies. In terms of worldwide expenditure, the research and development industry is at the top. An increase in the number of R&D activities in the pharmaceutical and biotechnology industries biotechnology sectors, an increasing emphasis on the behaviour of various kinds of antibodies attaching to antigens, and product advancements are expected to fuel the market.
Healthcare is one of the most heavily regulated businesses on the planet. Clinical institutions and organizations must follow regulatory rules to preserve the privacy of patient information and the protection of healthcare workers in order to avoid fraud. Biotechnology and pharmaceutical industries demand large investments. Antibodies, for example, are being studied in research. It takes time to develop monoclonal and polyclonal antibodies. Antibodies are coupled to antigens and injected into an organism for testing. The serum then collects the observation and transports it. When the research is finished, the samples are sent to the FDA permission is required. The implementation of stringent rules is projected to impede the entry of new market competitors.
Segmental Outlook
By Type Segment
Based on types, the global antibody market is divided into monoclonal antibodies, polyclonal antibodies, ADCs, and others. Their use in the treatment of illnesses such as coronavirus, monoclonal antibodies are expected to have a large share of the market over the forecast period. Increase in cancer patients throughout the world, ADCs used to treat malignant tumours are rapidly growing popularity. Monoclonal antibody drugs are expensive to manufacture, but they are widely available in the market, making them accessible to customers, which drives the market. Polyclonal antibodies are predicted to proliferate rapidly due to their ability to bind many antigen epitopes.
By Technology Segment
In terms of technology, the global antibody market is classified into western blotting, flow cytometry, ELISA, immunohistochemistry, immunofluorescence, immunoprecipitation, and others. Owing to the precision, the western blotting segment is expected to occupy a considerable proportion of the market over the projection period. Antibodies to HIV were detected as a consequence of the tests. Flow cytometry is thought to be rapidly expanding since it can do multi-parameter analysis on single cells inside a sample combination that is heterogeneous.
By Applications Segment
In terms of applications, the global antibody market is classified into proteomics, drug development, and genomics. Owing to the efficient mapping of drug-protein and protein-protein interactions, the proteomics sector is expected to occupy a major proportion of the market over the projected period. The drug development segment is expected to expand rapidly, since it facilitates the release of sophisticated drugs and vaccines following FDA clearance. Attributing to advancements in genetic research of an organism and chances for cancer patients using stem cell treatment, the genomics segment is predicted to increase at a significant rate.
By End-users Segment
Based on end-users, the global antibody market is classified as pharmaceutical and biotechnology companies, academic and research institutes, and CROs. The introduction of medicines and vaccines for horrible illnesses, pharmaceutical and biotechnology firms are expected to have a large proportion of the market throughout the predicted period. CROs are expected to increase at a high rate, since they assist clinical studies of newly marketed vaccines and medications prior to market release. As a comprehensive study of illnesses is completed and a deep understanding of antigen is supplied, the academic and research institutions segment is predicted to increase at a quick rate.
Region Wise Outlook
Based on regions, the global antibody market is fragmented into North America, Europe, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2019. During the projected period, the market in Latin America, the Middle East and Africa, and Europe is expected to grow at a considerable CAGR. During the forecast period, North America is expected to have the greatest share. Stem cell treatment research and technological improvements are offering attractive prospects for participants in this field. Due to the increased frequency of chronic illnesses such as cardiovascular and blood illnesses, Europe is likely to occupy a significant market share. Due to research and development initiatives, Asia Pacific is a potential area for the antibody market. The collaboration of several medical institutes and academic institutions is expected to improve the situation.
Key Benefits for Industry Participants & Stakeholders
In-depth Analysis of the Global Antibody Market
Historical, Current and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global Antibody Market Performance
Segments
Key Segments Covered
By Type
Monoclonal Antibodies
Polyclonal Antibodies
ADCs
Others
By Technology
Western Blotting
Flow Cytometry
ELISA
Immunohistochemistry
Immunofluorescence
Immunoprecipitation
Others
By Applications
Proteomics
Drug Development
Genomics
By End-users
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
CROs
By Regions
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Key Market Players Profiled in the Report
AbbVie Inc.
YASHRAJ BIOTECHNOLOGY LTD.
QIAGEN
Novartis AG
F. Hoffmann-La Roche Ltd
Cell Signaling Technology, Inc.
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Becton, Dickinson and Company
Merck KGaA
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
Alexion Pharmaceuticals, Inc.
GenScript
Precision BioLogic Incorporated Liberty Materials Inc
signal peak silica
Eagle Materials, Inc.
Competitive Landscape
Key players in the market include AbbVie Inc., YASHRAJ BIOTECHNOLOGY LTD., QIAGEN, Novartis AG, Hoffmann-La Roche Ltd, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Merck KGaA , Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Alexion Pharmaceuticals, Inc., GenScript, and Precision BioLogic Incorporated. These players are considered as key manufacturers of the market based on different varieties of product availability, regional presence, better supply chain management system, and the increasing demand for the products. The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition and many other strategies to increase their demand for global antibody market.
Chapter 1 Executive Summary Chapter 2 Assumptions and Acronyms Used Chapter 3 Research Methodology Chapter 4 Antibody Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Antibody Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Antibody Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Antibody Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Antibody Market Size & Forecast, 2017-2027 4.5.1 Antibody Market Size and Y-o-Y Growth 4.5.2 Antibody Market Absolute $ Opportunity 4.6 Global Antibody Market: Impact Of Key Regulations Chapter 5 Global Antibody Market Analysis and Forecast By Type 5.1 Introduction 5.1.1 Key Market Trends & Growth Opportunities By Type 5.1.2 Basis Point Share (BPS) Analysis By Type 5.1.3 Absolute $ Opportunity Assessment By Type 5.2 Antibody Market Size Forecast By Type 5.2.1 Monoclonal Antibodies 5.2.2 Polyclonal Antibodies 5.2.3 ADCS 5.2.4 Others 5.3 Market Attractiveness Analysis By Type Chapter 6 Global Antibody Market Analysis and Forecast By Technology 6.1 Introduction 6.1.1 Key Market Trends & Growth Opportunities By Technology 6.1.2 Basis Point Share (BPS) Analysis By Technology 6.1.3 Absolute $ Opportunity Assessment By Technology 6.2 Antibody Market Size Forecast By Technology 6.2.1 Western Blotting 6.2.2 Flow Cytometry 6.2.3 ELISA 6.2.4 Immunohistochemistry 6.2.5 Immunofluorescence 6.2.6 Immunoprecipitation 6.2.7 Others 6.3 Market Attractiveness Analysis By Technology Chapter 7 Global Antibody Market Analysis and Forecast By Application 7.1 Introduction 7.1.1 Key Market Trends & Growth Opportunities By Application 7.1.2 Basis Point Share (BPS) Analysis By Application 7.1.3 Absolute $ Opportunity Assessment By Application 7.2 Antibody Market Size Forecast By Application 7.2.1 Into Proteomics 7.2.2 Drug Development 7.2.3 Genomics 7.3 Market Attractiveness Analysis By Application Chapter 8 Global Antibody Market Analysis and Forecast By End-User 8.1 Introduction 8.1.1 Key Market Trends & Growth Opportunities By End-User 8.1.2 Basis Point Share (BPS) Analysis By End-User 8.1.3 Absolute $ Opportunity Assessment By End-User 8.2 Antibody Market Size Forecast By End-User 8.2.1 Pharmaceutical and Biotechnology Companies 8.2.2 Academic and Research Institutes 8.2.3 CROs 8.3 Market Attractiveness Analysis By End-User Chapter 9 Global Antibody Market Analysis and Forecast by Region 9.1 Introduction 9.1.1 Key Market Trends & Growth Opportunities by Region 9.1.2 Basis Point Share (BPS) Analysis by Region 9.1.3 Absolute $ Opportunity Assessment by Region 9.2 Antibody Market Size Forecast by Region 9.2.1 North America 9.2.2 Europe 9.2.3 Asia Pacific 9.2.4 Latin America 9.2.5 Middle East & Africa (MEA) 9.3 Market Attractiveness Analysis by Region Chapter 10 Coronavirus Disease (COVID-19) Impact 10.1 Introduction 10.2 Current & Future Impact Analysis 10.3 Economic Impact Analysis 10.4 Government Policies 10.5 Investment Scenario Chapter 11 North America Antibody Analysis and Forecast 11.1 Introduction 11.2 North America Antibody Market Size Forecast by Country 11.2.1 U.S. 11.2.2 Canada 11.3 Basis Point Share (BPS) Analysis by Country 11.4 Absolute $ Opportunity Assessment by Country 11.5 Market Attractiveness Analysis by Country 11.6 North America Antibody Market Size Forecast By Type 11.6.1 Monoclonal Antibodies 11.6.2 Polyclonal Antibodies 11.6.3 ADCS 11.6.4 Others 11.7 Basis Point Share (BPS) Analysis By Type 11.8 Absolute $ Opportunity Assessment By Type 11.9 Market Attractiveness Analysis By Type 11.10 North America Antibody Market Size Forecast By Technology 11.10.1 Western Blotting 11.10.2 Flow Cytometry 11.10.3 ELISA 11.10.4 Immunohistochemistry 11.10.5 Immunofluorescence 11.10.6 Immunoprecipitation 11.10.7 Others 11.11 Basis Point Share (BPS) Analysis By Technology 11.12 Absolute $ Opportunity Assessment By Technology 11.13 Market Attractiveness Analysis By Technology 11.14 North America Antibody Market Size Forecast By Application 11.14.1 Into Proteomics 11.14.2 Drug Development 11.14.3 Genomics 11.15 Basis Point Share (BPS) Analysis By Application 11.16 Absolute $ Opportunity Assessment By Application 11.17 Market Attractiveness Analysis By Application 11.18 North America Antibody Market Size Forecast By End-User 11.18.1 Pharmaceutical and Biotechnology Companies 11.18.2 Academic and Research Institutes 11.18.3 CROs 11.19 Basis Point Share (BPS) Analysis By End-User 11.20 Absolute $ Opportunity Assessment By End-User 11.21 Market Attractiveness Analysis By End-User Chapter 12 Europe Antibody Analysis and Forecast 12.1 Introduction 12.2 Europe Antibody Market Size Forecast by Country 12.2.1 Germany 12.2.2 France 12.2.3 Italy 12.2.4 U.K. 12.2.5 Spain 12.2.6 Russia 12.2.7 Rest of Europe 12.3 Basis Point Share (BPS) Analysis by Country 12.4 Absolute $ Opportunity Assessment by Country 12.5 Market Attractiveness Analysis by Country 12.6 Europe Antibody Market Size Forecast By Type 12.6.1 Monoclonal Antibodies 12.6.2 Polyclonal Antibodies 12.6.3 ADCS 12.6.4 Others 12.7 Basis Point Share (BPS) Analysis By Type 12.8 Absolute $ Opportunity Assessment By Type 12.9 Market Attractiveness Analysis By Type 12.10 Europe Antibody Market Size Forecast By Technology 12.10.1 Western Blotting 12.10.2 Flow Cytometry 12.10.3 ELISA 12.10.4 Immunohistochemistry 12.10.5 Immunofluorescence 12.10.6 Immunoprecipitation 12.10.7 Others 12.11 Basis Point Share (BPS) Analysis By Technology 12.12 Absolute $ Opportunity Assessment By Technology 12.13 Market Attractiveness Analysis By Technology 12.14 Europe Antibody Market Size Forecast By Application 12.14.1 Into Proteomics 12.14.2 Drug Development 12.14.3 Genomics 12.15 Basis Point Share (BPS) Analysis By Application 12.16 Absolute $ Opportunity Assessment By Application 12.17 Market Attractiveness Analysis By Application 12.18 Europe Antibody Market Size Forecast By End-User 12.18.1 Pharmaceutical and Biotechnology Companies 12.18.2 Academic and Research Institutes 12.18.3 CROs 12.19 Basis Point Share (BPS) Analysis By End-User 12.20 Absolute $ Opportunity Assessment By End-User 12.21 Market Attractiveness Analysis By End-User Chapter 13 Asia Pacific Antibody Analysis and Forecast 13.1 Introduction 13.2 Asia Pacific Antibody Market Size Forecast by Country 13.2.1 China 13.2.2 Japan 13.2.3 South Korea 13.2.4 India 13.2.5 Australia 13.2.6 South East Asia (SEA) 13.2.7 Rest of Asia Pacific (APAC) 13.3 Basis Point Share (BPS) Analysis by Country 13.4 Absolute $ Opportunity Assessment by Country 13.5 Market Attractiveness Analysis by Country 13.6 Asia Pacific Antibody Market Size Forecast By Type 13.6.1 Monoclonal Antibodies 13.6.2 Polyclonal Antibodies 13.6.3 ADCS 13.6.4 Others 13.7 Basis Point Share (BPS) Analysis By Type 13.8 Absolute $ Opportunity Assessment By Type 13.9 Market Attractiveness Analysis By Type 13.10 Asia Pacific Antibody Market Size Forecast By Technology 13.10.1 Western Blotting 13.10.2 Flow Cytometry 13.10.3 ELISA 13.10.4 Immunohistochemistry 13.10.5 Immunofluorescence 13.10.6 Immunoprecipitation 13.10.7 Others 13.11 Basis Point Share (BPS) Analysis By Technology 13.12 Absolute $ Opportunity Assessment By Technology 13.13 Market Attractiveness Analysis By Technology 13.14 Asia Pacific Antibody Market Size Forecast By Application 13.14.1 Into Proteomics 13.14.2 Drug Development 13.14.3 Genomics 13.15 Basis Point Share (BPS) Analysis By Application 13.16 Absolute $ Opportunity Assessment By Application 13.17 Market Attractiveness Analysis By Application 13.18 Asia Pacific Antibody Market Size Forecast By End-User 13.18.1 Pharmaceutical and Biotechnology Companies 13.18.2 Academic and Research Institutes 13.18.3 CROs 13.19 Basis Point Share (BPS) Analysis By End-User 13.20 Absolute $ Opportunity Assessment By End-User 13.21 Market Attractiveness Analysis By End-User Chapter 14 Latin America Antibody Analysis and Forecast 14.1 Introduction 14.2 Latin America Antibody Market Size Forecast by Country 14.2.1 Brazil 14.2.2 Mexico 14.2.3 Rest of Latin America (LATAM) 14.3 Basis Point Share (BPS) Analysis by Country 14.4 Absolute $ Opportunity Assessment by Country 14.5 Market Attractiveness Analysis by Country 14.6 Latin America Antibody Market Size Forecast By Type 14.6.1 Monoclonal Antibodies 14.6.2 Polyclonal Antibodies 14.6.3 ADCS 14.6.4 Others 14.7 Basis Point Share (BPS) Analysis By Type 14.8 Absolute $ Opportunity Assessment By Type 14.9 Market Attractiveness Analysis By Type 14.10 Latin America Antibody Market Size Forecast By Technology 14.10.1 Western Blotting 14.10.2 Flow Cytometry 14.10.3 ELISA 14.10.4 Immunohistochemistry 14.10.5 Immunofluorescence 14.10.6 Immunoprecipitation 14.10.7 Others 14.11 Basis Point Share (BPS) Analysis By Technology 14.12 Absolute $ Opportunity Assessment By Technology 14.13 Market Attractiveness Analysis By Technology 14.14 Latin America Antibody Market Size Forecast By Application 14.14.1 Into Proteomics 14.14.2 Drug Development 14.14.3 Genomics 14.15 Basis Point Share (BPS) Analysis By Application 14.16 Absolute $ Opportunity Assessment By Application 14.17 Market Attractiveness Analysis By Application 14.18 Latin America Antibody Market Size Forecast By End-User 14.18.1 Pharmaceutical and Biotechnology Companies 14.18.2 Academic and Research Institutes 14.18.3 CROs 14.19 Basis Point Share (BPS) Analysis By End-User 14.20 Absolute $ Opportunity Assessment By End-User 14.21 Market Attractiveness Analysis By End-User Chapter 15 Middle East & Africa (MEA) Antibody Analysis and Forecast 15.1 Introduction 15.2 Middle East & Africa (MEA) Antibody Market Size Forecast by Country 15.2.1 Saudi Arabia 15.2.2 South Africa 15.2.3 UAE 15.2.4 Rest of Middle East & Africa (MEA) 15.3 Basis Point Share (BPS) Analysis by Country 15.4 Absolute $ Opportunity Assessment by Country 15.5 Market Attractiveness Analysis by Country 15.6 Middle East & Africa (MEA) Antibody Market Size Forecast By Type 15.6.1 Monoclonal Antibodies 15.6.2 Polyclonal Antibodies 15.6.3 ADCS 15.6.4 Others 15.7 Basis Point Share (BPS) Analysis By Type 15.8 Absolute $ Opportunity Assessment By Type 15.9 Market Attractiveness Analysis By Type 15.10 Middle East & Africa (MEA) Antibody Market Size Forecast By Technology 15.10.1 Western Blotting 15.10.2 Flow Cytometry 15.10.3 ELISA 15.10.4 Immunohistochemistry 15.10.5 Immunofluorescence 15.10.6 Immunoprecipitation 15.10.7 Others 15.11 Basis Point Share (BPS) Analysis By Technology 15.12 Absolute $ Opportunity Assessment By Technology 15.13 Market Attractiveness Analysis By Technology 15.14 Middle East & Africa (MEA) Antibody Market Size Forecast By Application 15.14.1 Into Proteomics 15.14.2 Drug Development 15.14.3 Genomics 15.15 Basis Point Share (BPS) Analysis By Application 15.16 Absolute $ Opportunity Assessment By Application 15.17 Market Attractiveness Analysis By Application 15.18 Middle East & Africa (MEA) Antibody Market Size Forecast By End-User 15.18.1 Pharmaceutical and Biotechnology Companies 15.18.2 Academic and Research Institutes 15.18.3 CROs 15.19 Basis Point Share (BPS) Analysis By End-User 15.20 Absolute $ Opportunity Assessment By End-User 15.21 Market Attractiveness Analysis By End-User Chapter 16 Competition Landscape 16.1 Antibody Market: Competitive Dashboard 16.2 Global Antibody Market: Market Share Analysis, 2019 16.3 Company Profiles (Details - Overview, Financials, Developments, Strategy) 16.3.1 AbbVie Inc. 16.3.2 YASHRAJ BIOTECHNOLOGY LTD. 16.3.3 QIAGEN 16.3.4 Novartis AG 16.3.5 F. Hoffmann-La Roche Ltd 16.3.6 Cell Signaling Technology, Inc. 16.3.7 Bio-Rad Laboratories, Inc. 16.3.8 Agilent Technologies, Inc. 16.3.9 Becton, Dickinson and Company 16.3.10 Merck KGaA 16.3.11 Johnson & Johnson Services, Inc. 16.3.12 Bristol-Myers Squibb Company 16.3.13 Alexion Pharmaceuticals, Inc. 16.3.14 GenScript 16.3.15 Precision BioLogic Incorporated
Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you. Strategy Head of Major Tech Company
We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality. Major Player in Defense Industry
Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions. CMO of Leading Packaging Company from USA
I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data. Founder and Managing Partner of Major Korean Company
Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports. Global Consulting Firm
According to this Growth Market Reports, report, the market from global antibody market is likely to register a CAGR of 10.1% during period 2020-2027, with an anticipated valuation of USD 318,482.1 Mn by the end of the 2027.
In addition to market size (in USD Million) and Company Market Share (in % for base year 2019), other data such Macro-economic factors, COVID-19 Impact on the global antibody market is available in final report.
The global antibody market is anticipated to grow significantly during forecast period due increasing demand of fast recovery, growing number of patients with diabetic and cardiovascular disorders.
Pharmaceutical and biotechnology companies, academic and research institutes, and CROs are few of the key end use industries driving the market growth.
The market is expected to witness growth at a fast pace with increase in terms of demand during 2019-2020 owing to the positive impact of COVID-19 pandemic on the global antibody market.
The base year considered for the global antibody market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years, 2020 is an estimated year and the forecast is provided from 2021 to 2027.
Request For Customization
Enquiry Before Buying
Speak With Analyst
